Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Clarified Precision Medicine is a private precision-oncology healthcare technology company that provides clinicians with rapid, guideline-based treatment recommendations derived from tumor genomic profiling. The company operates a scalable asynchronous molecular tumor board model that combines machine learning and AI-enabled analytics with expert physician and pharmacist review. Its core offerings include ClarifiedSelect for ranked therapy recommendations and OncoGuardian for pharmacogenomics guidance. Clarified works with providers, payers, life sciences companies, and laboratories to improve use of targeted therapies, lower delays in care, and generate actionable patient-level insights. The business appears to be a commercial-stage services and software-enabled care company rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Clarified Precision Medicine.